002693 双成药业
已收盘 06-12 15:00:00
资讯
新帖
简况
股市必读：双成药业（002693）6月1日收盘跌7.97%，主力净流出530.28万元
证券之星 · 06-02
股市必读：双成药业（002693）6月1日收盘跌7.97%，主力净流出530.28万元
股市必读：双成药业（002693）5月27日收盘跌6.61%，主力净流入2750.66万元
证券之星 · 05-28
股市必读：双成药业（002693）5月27日收盘跌6.61%，主力净流入2750.66万元
股市必读：*ST双成（002693）新发布《上会会计师事务所（特殊普通合伙）关于海南双成药业股份有限公司对深圳证券交易所2025 年年报问询函的回复》
证券之星 · 05-25
股市必读：*ST双成（002693）新发布《上会会计师事务所（特殊普通合伙）关于海南双成药业股份有限公司对深圳证券交易所2025 年年报问询函的回复》
股市必读：*ST双成（002693）新发布《上会会计师事务所（特殊普通合伙）关于海南双成药业股份有限公司对深圳证券交易所2025 年年报问询函的回复》
证券之星 · 05-22
股市必读：*ST双成（002693）新发布《上会会计师事务所（特殊普通合伙）关于海南双成药业股份有限公司对深圳证券交易所2025 年年报问询函的回复》
*ST双成最新公告：撤销退市风险警示股票简称变更为“双成药业”
证券之星 · 05-21
*ST双成最新公告：撤销退市风险警示股票简称变更为“双成药业”
海南双成药业5月22日停牌一日，旨在撤销退市风险警示
美股速递 · 05-21
海南双成药业5月22日停牌一日，旨在撤销退市风险警示
异动快报：*ST双成（002693）5月14日10点5分触及涨停板
证券之星 · 05-14
异动快报：*ST双成（002693）5月14日10点5分触及涨停板
*ST双成（002693）披露关于申请撤销退市风险警示的进展公告，5月13日股价下跌2.46%
证券之星 · 05-13
*ST双成（002693）披露关于申请撤销退市风险警示的进展公告，5月13日股价下跌2.46%
5月11日*ST双成（002693）龙虎榜数据：机构净买入1839.84万元（3日）
证券之星 · 05-11
5月11日*ST双成（002693）龙虎榜数据：机构净买入1839.84万元（3日）
异动快报：*ST双成（002693）5月8日13点56分触及涨停板
证券之星 · 05-08
异动快报：*ST双成（002693）5月8日13点56分触及涨停板
*ST双成（002693）披露将参加海南辖区上市公司2025年年报业绩说明会暨投资者网上集体接待日活动，5月6日股价上涨1.52%
证券之星 · 05-06
*ST双成（002693）披露将参加海南辖区上市公司2025年年报业绩说明会暨投资者网上集体接待日活动，5月6日股价上涨1.52%
每周股票复盘：*ST双成（002693）一季报净利增134.34%
证券之星 · 05-03
每周股票复盘：*ST双成（002693）一季报净利增134.34%
*ST双成（002693）2026年一季报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 04-30
*ST双成（002693）2026年一季报简析：营收净利润同比双双增长，应收账款上升
异动快报：*ST双成（002693）4月29日10点37分触及跌停板
证券之星 · 04-29
异动快报：*ST双成（002693）4月29日10点37分触及跌停板
图解*ST双成一季报：第一季度单季净利润同比增长134.34%
证券之星 · 04-29
图解*ST双成一季报：第一季度单季净利润同比增长134.34%
*ST双成（002693）披露2026年一季度报告，4月28日股价上涨3.07%
证券之星 · 04-28
*ST双成（002693）披露2026年一季度报告，4月28日股价上涨3.07%
*ST双成（002693）披露关于申请撤销退市风险警示的公告，4月20日股价上涨1.41%
中金财经 · 04-20
*ST双成（002693）披露关于申请撤销退市风险警示的公告，4月20日股价上涨1.41%
*ST双成（002693）2025年年报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 04-19
*ST双成（002693）2025年年报简析：营收净利润同比双双增长，应收账款上升
*ST双成(002693)3月31日股东户数3.22万户，较上期减少16.75%
证券之星 · 04-18
*ST双成(002693)3月31日股东户数3.22万户，较上期减少16.75%
图解*ST双成年报：第四季度单季净利润同比增长153.29%
证券之星 · 04-18
图解*ST双成年报：第四季度单季净利润同比增长153.29%
加载更多
公司概况
公司名称：
海南双成药业股份有限公司
所属行业：
医药制造业
上市日期：
2012-08-08
主营业务：
海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用紫杉醇（白蛋白结合型）、注射用胸腺法新、注射用生长抑素、注射用比伐芦定、依替巴肽注射液、醋酸奥曲肽注射液。
发行价格：
20.00
{"stockData":{"symbol":"002693","market":"SZ","secType":"STK","nameCN":"双成药业","latestPrice":9.17,"timestamp":1781247816000,"preClose":9,"halted":0,"volume":11000500,"delay":0,"changeRate":0.0189,"floatShares":411000000,"shares":415000000,"eps":0.0785,"marketStatus":"已收盘","change":0.17,"latestTime":"06-12 15:00:00","open":9.17,"high":9.3,"low":9,"amount":101000000,"amplitude":0.0333,"askPrice":9.18,"askSize":164,"bidPrice":9.17,"bidSize":233,"shortable":0,"etf":0,"ttmEps":0.0785,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"adjPreClose":9,"symbolType":"stock","openAndCloseTimeList":[[1781227800000,1781235000000],[1781240400000,1781247600000]],"highLimit":9.9,"lowLimit":8.1,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":414689750,"isCdr":false,"pbRate":8.97,"roa":"--","peRate":116.815287,"roe":"0.83%","epsLYR":0.05,"committee":0.072106,"marketValue":3803000000,"turnoverRate":0.0268,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-06-15。","floatMarketCap":3769000000},"requestUrl":"/m/hq/s/002693/","defaultTab":"news","newsList":[{"id":"2640296608","title":"股市必读：双成药业（002693）6月1日收盘跌7.97%，主力净流出530.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640296608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640296608?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:00","pubTimestamp":1780336843,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，双成药业报收于9.82元，下跌7.97%，换手率6.83%，成交量28.08万手，成交额2.81亿元。来自交易信息汇总：该股近5个交易日中有2日跌幅超5%，前10个交易日主力资金累计净流出1.47亿元，股价累计下跌8.27%。交易信息汇总股价提醒6月1日双成药业收盘报9.82元，跌7.97%，当日成交2.81亿元。资金流向6月1日主力资金净流出530.28万元；游资资金净流出463.38万元；散户资金净流入993.67万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638687259","title":"股市必读：双成药业（002693）5月27日收盘跌6.61%，主力净流入2750.66万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638687259","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638687259?lang=zh_cn&edition=full","pubTime":"2026-05-28 01:18","pubTimestamp":1779902291,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘，双成药业报收于10.74元，下跌6.61%，换手率8.78%，成交量36.09万手，成交额3.9亿元。来自资金流向：5月27日主力资金净流入2750.66万元，扭转此前资金流出趋势。交易信息汇总股价提醒5月27日双成药业收盘报10.74元，跌6.61%，当日成交3609.29万元。该股已连续2日下跌。前10个交易日中，主力资金累计净流出1.46亿元，股价累计下跌4.12%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638006283","title":"股市必读：*ST双成（002693）新发布《上会会计师事务所（特殊普通合伙）关于海南双成药业股份有限公司对深圳证券交易所2025 年年报问询函的回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2638006283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638006283?lang=zh_cn&edition=full","pubTime":"2026-05-25 05:08","pubTimestamp":1779656895,"startTime":"0","endTime":"0","summary":"公司公告汇总海南双成药业股份有限公司关于对深圳证券交易所2025年年报问询函的回复公告公司2025年实现营业收入2.77亿元，同比增长58.87%，主要因注射用紫杉醇获美国FDA上市许可并实现出口销售，该产品贡献收入1.41亿元，占总营收50.98%。海南双成药业股份有限公司关于公司股票交易撤销退市风险警示暨停复牌的公告公司股票于2026年5月22日开市起停牌1天，2026年5月25日开市起复牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500002113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693","399001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637356285","title":"股市必读：*ST双成（002693）新发布《上会会计师事务所（特殊普通合伙）关于海南双成药业股份有限公司对深圳证券交易所2025 年年报问询函的回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2637356285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637356285?lang=zh_cn&edition=full","pubTime":"2026-05-22 02:36","pubTimestamp":1779388572,"startTime":"0","endTime":"0","summary":"北京市中伦律师事务所关于海南双成药业股份有限公司2025年年度报告问询函相关事项的专项核查意见经核查，公司2025年度利润总额、净利润、扣非后净利润均为正值，营业收入为27,676.12万元，净资产为41,245.74万元，审计报告为标准无保留意见。上会会计师事务所关于海南双成药业股份有限公司对深圳证券交易所2025 年年报问询函的回复公司2025年实现营业收入2.77亿元，同比增长58.87%，主要原因为注射用紫杉醇获批FDA并实现海外销售，贡献收入1.41亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200003126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693","399001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637593339","title":"*ST双成最新公告：撤销退市风险警示股票简称变更为“双成药业”","url":"https://stock-news.laohu8.com/highlight/detail?id=2637593339","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637593339?lang=zh_cn&edition=full","pubTime":"2026-05-21 21:00","pubTimestamp":1779368435,"startTime":"0","endTime":"0","summary":"*ST双成(002693.SZ)公告称，公司撤销退市风险警示的申请已获得深圳证券交易所审核同意。根据《深圳证券交易所股票上市规则》有关规定，公司股票将于2026年5月22日开市起停牌1天，并于2026年5月25日开市起撤销退市风险警示并复牌，证券简称由“*ST双成”变更为“双成药业”，证券代码仍为“002693”，股票交易日涨跌幅限制由“5%”变更为“10%”。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100042703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129264869","title":"海南双成药业5月22日停牌一日，旨在撤销退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=1129264869","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129264869?lang=zh_cn&edition=full","pubTime":"2026-05-21 20:55","pubTimestamp":1779368127,"startTime":"0","endTime":"0","summary":"海南双成药业股份有限公司发布公告，其股票将于5月22日停牌一天。此举旨在完成相关程序，以撤销对公司股票实施的“退市风险警示”特别处理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635765868","title":"异动快报：*ST双成（002693）5月14日10点5分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2635765868","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635765868?lang=zh_cn&edition=full","pubTime":"2026-05-14 10:10","pubTimestamp":1778724659,"startTime":"0","endTime":"0","summary":"证券之星5月14日盘中消息，10点5分*ST双成（002693）触及涨停板。其所属行业化学制药目前下跌。领涨股为昂利康。该股为半导体，医药，化学原料药概念热股，当日半导体概念上涨0.01%。5月13日的资金流向数据方面，主力资金净流出1565.55万元，占总成交额5.81%，游资资金净流入260.8万元，占总成交额0.97%，散户资金净流入1304.75万元，占总成交额4.84%。近5日资金流向一览见下表：*ST双成主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400012705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635005742","title":"*ST双成（002693）披露关于申请撤销退市风险警示的进展公告，5月13日股价下跌2.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635005742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635005742?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:47","pubTimestamp":1778665663,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，*ST双成报收于10.3元，较前一交易日下跌2.46%，最新总市值为42.71亿元。该股当日开盘10.5元，最高10.87元，最低10.15元，成交额达2.7亿元，换手率为6.26%。海南双成药业股份有限公司于2026年4月17日向深圳证券交易所提交了撤销退市风险警示的申请，目前该申请处于补充材料阶段。根据相关规定，补充材料期间不计入深交所作出决定的期限。公司将持续关注进展并履行信息披露义务。申请能否获批存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300032949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634047314","title":"5月11日*ST双成（002693）龙虎榜数据：机构净买入1839.84万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2634047314","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634047314?lang=zh_cn&edition=full","pubTime":"2026-05-11 17:30","pubTimestamp":1778491834,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年5月11日公布的交易公开信息显示，*ST双成因连续三个交易日内，涨幅偏离值累计达到12%的ST证券、*ST证券和未完成股改证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年5月11日收盘，*ST双成报收于10.06元，上涨5.01%，换手率5.26%，成交量21.61万手，成交额2.11亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入1839.84万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100024280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633489099","title":"异动快报：*ST双成（002693）5月8日13点56分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2633489099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633489099?lang=zh_cn&edition=full","pubTime":"2026-05-08 14:00","pubTimestamp":1778220055,"startTime":"0","endTime":"0","summary":"证券之星5月8日盘中消息，13点56分*ST双成触及涨停板。其所属行业化学制药目前上涨。领涨股为ST诺泰。该股为肝炎概念，海南概念，化学原料药概念热股，当日肝炎概念概念上涨1.73%，海南概念概念上涨1.26%，化学原料药概念上涨0.24%。5月7日的资金流向数据方面，主力资金净流入2954.87万元，占总成交额17.81%，游资资金净流出1619.2万元，占总成交额9.76%，散户资金净流出1335.66万元，占总成交额8.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800020915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633189741","title":"*ST双成（002693）披露将参加海南辖区上市公司2025年年报业绩说明会暨投资者网上集体接待日活动，5月6日股价上涨1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633189741","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633189741?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:26","pubTimestamp":1778063179,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，*ST双成报收于8.71元，较前一交易日上涨1.52%，最新总市值为36.12亿元。该股当日开盘8.55元，最高8.88元，最低8.55元，成交额达9259.17万元，换手率为2.58%。近日，海南双成药业股份有限公司发布《关于参加海南辖区上市公司2025年年报业绩说明会暨投资者网上集体接待日活动的公告》。公司高管将在活动中就2025年度业绩、公司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等话题与投资者进行在线交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600032177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632677440","title":"每周股票复盘：*ST双成（002693）一季报净利增134.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632677440","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632677440?lang=zh_cn&edition=full","pubTime":"2026-05-03 06:00","pubTimestamp":1777759243,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，*ST双成报收于8.58元，较上周的8.55元上涨0.35%。本周，*ST双成4月28日盘中最高价报9.23元。本周关注点来自业绩披露要点：*ST双成2026年一季报归母净利润344.82万元，同比上升134.34%。来自公司公告汇总：*ST双成一季度营收48,439,867.75元，同比增长32.08%，实现同比扭亏为盈。股本股东变化股东户数变动截至2026年3月31日，*ST双成股东户数为3.22万户，较2025年12月31日减少6483.0户，减幅16.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631520205","title":"*ST双成（002693）2026年一季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631520205","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631520205?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:36","pubTimestamp":1777502175,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期*ST双成发布2026年一季报。截至本报告期末，公司营业总收入4843.99万元，同比上升32.08%，归母净利润344.82万元，同比上升134.34%。本报告期*ST双成应收账款上升，应收账款同比增幅达296.13%。去年的净利率为3.22%，算上全部成本后，公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000022014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631255435","title":"异动快报：*ST双成（002693）4月29日10点37分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2631255435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631255435?lang=zh_cn&edition=full","pubTime":"2026-04-29 10:42","pubTimestamp":1777430560,"startTime":"0","endTime":"0","summary":"证券之星4月29日盘中消息，10点37分*ST双成触及跌停板。其所属行业化学制药目前上涨。领涨股为广生堂。该股为海南概念，肝炎概念，阿尔茨海默病概念热股，当日海南概念概念上涨0.78%，肝炎概念概念上涨0.64%，阿尔茨海默病概念上涨0.44%。4月28日的资金流向数据方面，主力资金净流入902.58万元，占总成交额5.1%，游资资金净流出758.45万元，占总成交额4.28%，散户资金净流出144.13万元，占总成交额0.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900034313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631531009","title":"图解*ST双成一季报：第一季度单季净利润同比增长134.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631531009","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631531009?lang=zh_cn&edition=full","pubTime":"2026-04-29 05:32","pubTimestamp":1777411961,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成2026年一季报显示，一季度公司主营收入4843.99万元，同比上升32.08%；归母净利润344.82万元，同比上升134.34%；扣非净利润285.38万元，同比上升125.73%；负债率48.55%，投资收益-0.01万元，财务费用393.74万元，毛利率62.35%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900012453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630583717","title":"*ST双成（002693）披露2026年一季度报告，4月28日股价上涨3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630583717","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630583717?lang=zh_cn&edition=full","pubTime":"2026-04-28 22:18","pubTimestamp":1777385881,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，*ST双成报收于9.06元，较前一交易日上涨3.07%，最新总市值为37.57亿元。该股当日开盘8.78元，最高9.23元，最低8.71元，成交额达1.77亿元，换手率为4.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800064988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628774105","title":"*ST双成（002693）披露关于申请撤销退市风险警示的公告，4月20日股价上涨1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628774105","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628774105?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:20","pubTimestamp":1776680429,"startTime":"0","endTime":"0","summary":"海南双成药业股份有限公司于近日披露《关于申请撤销退市风险警示的公告》。公告显示，公司因2024年度经审计的净利润为负且扣除后的营业收入低于3亿元，股票自2025年4月30日起被实施退市风险警示。2026年4月16日，公司召开董事会审议通过申请撤销退市风险警示的议案。根据2025年度经审计财务数据，公司利润总额、净利润、扣非后净利润均为正值，营业收入为27,676.12万元，净资产为41,245.74万元，符合撤销退市风险警示条件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260420/32157506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628754080","title":"*ST双成（002693）2025年年报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2628754080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628754080?lang=zh_cn&edition=full","pubTime":"2026-04-19 06:13","pubTimestamp":1776550395,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期*ST双成发布2025年年报。截至本报告期末，公司营业总收入2.77亿元，同比上升58.87%，归母净利润1904.32万元，同比上升124.32%。本报告期*ST双成应收账款上升，应收账款同比增幅达419.5%。去年的净利率为3.22%，算上全部成本后，公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628073269","title":"*ST双成(002693)3月31日股东户数3.22万户，较上期减少16.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628073269","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628073269?lang=zh_cn&edition=full","pubTime":"2026-04-18 17:06","pubTimestamp":1776503168,"startTime":"0","endTime":"0","summary":"证券之星消息，近日*ST双成披露，截至2026年3月31日公司股东户数为3.22万户，较12月31日减少6483.0户，减幅为16.75%。在化学制药行业个股中，*ST双成股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.53万户。从股价来看，2025年12月31日至2026年3月31日，*ST双成区间涨幅为14.51%，在此期间股东户数减少6483.0户，减幅为16.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800018728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628785619","title":"图解*ST双成年报：第四季度单季净利润同比增长153.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628785619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628785619?lang=zh_cn&edition=full","pubTime":"2026-04-18 01:09","pubTimestamp":1776445753,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成2025年年报显示，当年度公司主营收入2.77亿元，同比上升58.87%；归母净利润1904.32万元，同比上升124.32%；扣非净利润1522.77万元，同比上升121.24%；其中2025年第四季度，公司单季度主营收入1.08亿元，同比上升128.29%；单季度归母净利润2156.66万元，同比上升153.29%；单季度扣非净利润2109.38万元，同比上升166.37%；负债率49.07%，投资收益56.27万元，财务费用1045.58万元，毛利率54.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800002340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781372164761,"stockEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.1097},{"period":"3month","weight":0.1956},{"period":"6month","weight":0.3328},{"period":"1year","weight":0.1682},{"period":"ytd","weight":0.3175}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.0158}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南双成药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"32225人(较上一季度减少16.75%)","perCapita":"12753股","listingDate":"2012-08-08","address":"海南省海口市秀英区兴国路16号","registeredCapital":"41468万元","survey":" 海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用紫杉醇（白蛋白结合型）、注射用胸腺法新、注射用生长抑素、注射用比伐芦定、依替巴肽注射液、醋酸奥曲肽注射液。","listedPrice":20},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"双成药业(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供双成药业(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"双成药业,002693,双成药业股票,双成药业股票老虎,双成药业股票老虎国际,双成药业行情,双成药业股票行情,双成药业股价,双成药业股市,双成药业股票价格,双成药业股票交易,双成药业股票购买,双成药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"双成药业(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供双成药业(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}